相关实验视频

Updated: Sep 17, 2025

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

在COPD中,通过个别治疗效果模型识别阿兹罗米辛反应者

Kenneth Verstraete^1,2, Iwein Gyselinck^1,3, Helene Huts^1,2

¹Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), KU Leuven, Leuven, Belgium.

|July 3, 2025

概括

长期使用阿齐思罗米可以有效地预防慢性阻塞性肺病 (COPD) 的恶化. 一个机器学习模型确定了一小部分显著受益的患者,从而实现了个性化的预防性治疗策略.

科学领域:

肺部医学肺部医学
药理学药理学是指药理学的学科.
医疗保健中的机器学习

背景情况:

长期使用阿齐思罗米有效预防慢性阻塞性肺病 (COPD) 恶化.
识别受益最多的患者至关重要,以尽量减少不必要的暴露和优化治疗.

研究的目的:

评估阿齐思罗米辛在COPD患者中的治疗效果异质性.
为了估计个性化预防治疗的个人治疗效应 (ITE).

主要方法:

利用了MACRO试验中的1025名患者的数据,以评估azithromycin在年度恶化率上的ITE.
采用了一个因果森林机器学习模型.
通过使用哥伦布试验中的83名患者的数据验证了这些发现.

主要成果:

一个具有最好的预测ITE的子组 (tertile) 在MACRO和哥伦布试验中显示出明显更大的恶化率减少.
在剩余的三分之二的患者中没有观察到显著的治疗效果.
ITE的主要预测因素包括呼吸系统症状,白细胞计数,血红蛋白,C反应蛋白和强迫生命能力.

结论:

鉴定了COPD中阿齐思罗米辛维持疗法的治疗效果异质性.
一小部分响应者推动了先前试验中观察到的平均恶化减少.
五个容易获得的参数可以预测ITE,帮助个性化治疗决策.

关键词:

慢性慢性肺炎恶化恶化慢性肺炎的药理学慢性肺炎的药理学药物反应药物反应肺部疾病,慢性阻塞性疾病

更多相关视频

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

相关概念视频

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...